Clinical trial
A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients
NCT00300846 · Otsuka Pharmaceutical Development & Commercialization, Inc., Industry · Completed
Key facts
| NCT number | NCT00300846 |
|---|---|
| Title | A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients |
| Official title | A Multicenter, Comparative, Randomized, Double-Blind, Placebo Controlled Study on the Effect on Weight of Adjunctive Treatment With Aripiprazole in Patients With Schizophrenia. |
| Lead sponsor | Otsuka Pharmaceutical Development & Commercialization, Inc., Industry |
| Collaborators | Otsuka America Pharmaceutical Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | aripiprazole, Placebo |
| Enrollment | 200 |
| Start date | Dec 1, 2005 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Mar 10, 2006 |
| Last update posted | Nov 8, 2013 |
| Countries | Austria, Czechia, Finland, France, Germany, Hungary, Poland, South Africa, Sweden, Switzerland, Turkey (Türkiye), United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: